Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-59337-4, published online 13 April 2024
The Supplementary Information published with this Article contained an error. In Supplementary Figure S1, panel f was a duplication of panel e. The original Supplementary Information file is provided below.
This error has now been corrected in the Supplementary Information file that accompanies the original Article.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Soleimani, M., Thi, M., Janfaza, S. et al. Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma. Sci Rep 15, 14900 (2025). https://doi.org/10.1038/s41598-025-99376-z
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-025-99376-z
